Angiogenic Signalling Pathways Altered in Gliomas: Selection Mechanisms for More Aggressive Neoplastic Subpopulations with Invasive Phenotype
Open Access
- 17 July 2012
- journal article
- review article
- Published by Hindawi Limited in Journal of Signal Transduction
- Vol. 2012, 1-10
Abstract
The angiogenesis process is a key event for glioma survival, malignancy and growth. The start of angiogenesis is mediated by a cascade of intratumoural events: alteration of the microvasculature network; a hypoxic microenvironment; adaptation of neoplastic cells and synthesis of pro-angiogenic factors. Due to a chaotic blood flow, a consequence of an aberrant microvasculature, tissue hypoxia phenomena are induced. Hypoxia inducible factor 1 is a major regulator in glioma invasiveness and angiogenesis. Clones of neoplastic cells with stem cell characteristics are selected by HIF-1. These cells, called “glioma stem cells” induce the synthesis of vascular endothelial growth factor. This factor is a pivotal mediator of angiogenesis. To elucidate the role of these angiogenic mediators during glioma growth, we have used a rat endogenous glioma model. Gliomas induced by prenatal ENU administration allowed us to study angiogenic events from early to advanced tumour stages. Events such as microvascular aberrations, hypoxia, GSC selection and VEGF synthesis may be studied in depth. Our data showed that for the treatment of gliomas, developing anti-angiogenic therapies could be aimed at GSCs, HIF-1 or VEGF. The ENU-glioma model can be considered to be a useful option to check novel designs of these treatment strategies.Keywords
This publication has 88 references indexed in Scilit:
- Primary brain tumors, neural stem cell, and brain tumor cancer cells: Where is the link?Neuropharmacology, 2010
- Binding to the Extracellular Matrix and Proteolytic Processing: Two Key Mechanisms Regulating Vascular Endothelial Growth Factor ActionMolecular Biology of the Cell, 2010
- Hypoxia inducible factors in cancer stem cellsBritish Journal of Cancer, 2010
- Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeuticsOncogene, 2009
- Brain cancer propagating cells: biology, genetics and targeted therapiesTrends in Molecular Medicine, 2009
- Turning Cancer Stem Cells Inside Out: An Exploration of Glioma Stem Cell Signaling PathwaysJournal of Biological Chemistry, 2009
- Hypoxia-Inducible Factors Regulate Tumorigenic Capacity of Glioma Stem CellsCancer Cell, 2009
- Prodeath or prosurvival: Two facets of hypoxia inducible factor-1 in perinatal brain injuryExperimental Neurology, 2009
- Glioma stem cells promote radioresistance by preferential activation of the DNA damage responseNature, 2006
- The biology of VEGF and its receptorsNature Medicine, 2003